Apricus (APRI) Pops Following Vitaros Distribution Agreement; Up ~4-5%
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Join SI Premium – FREE
Apricus Bioscience Inc. (Nasdaq: APRI) now up 3.9 percent following the announcement of a new distribution agreement for Vitaros in Canada with Abbott Laboratories Limited.
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
